Dergiler / Haseki Tıp Bülteni / 2021 / Cilt: 59 - Sayı: 5

The Efficacy of Combination Regime in Helicobacter Pylori Eradication: A Cross-Sectional Study from an Experienced Endoscopy Center

Sayfa
419–423
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It is appropriate to discuss the effectiveness of routine treatments and to take culture/antibiogram, even bismuth including preparations to the forefront

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: The success of antibiotics used for eradication in the treatment of Helicobacter pylori (Hp)-positive gastritis is controversial.
📊
Temel Bulgular & Veri:Methods: The data of 1,471 patients who underwent upper gastrointestinal endoscopy between January 1 and December 31, 2019, were retrospectively evaluated through the hospital digital recording system.
💡
Sonuç & Katkı:It is appropriate to discuss the effectiveness of routine treatments and to take culture/antibiogram, even bismuth including preparations to the forefront
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: The success of antibiotics used for eradication in the treatment of Helicobacter pylori (Hp)-positive gastritis is controversial. This study aims to evaluate the post-treatment eradication success/failure of Hp-positive gastritis cases, discuss antibiotic resistance, and what we can do additionally. Methods: The data of 1,471 patients who underwent upper gastrointestinal endoscopy between January 1 and December 31, 2019, were retrospectively evaluated through the hospital digital recording system. Of these, data of 126 patients who have been diagnosed with HP-positive gastritis and treated with a trio of clarithromycin, amoxicillin, and omeprazole were analyzed. Initial and control endoscopic pathologies and Hp-positivity were compared. Results: In the control of 126 patients, 87 (69%) patients had a normal endoscopic appearance, but only 46 (36.5%) patients were normal in the histopathological examinations of biopsies. Regardless of the severity, complete eradication of Hp was possible in 31 (24.6%) patients. There was no statistically significant difference in Hp detection rates after treatment (p=0.719 for 1+, p=0.583 for 2+, p for 3+)=0.980). Conclusion: In gastritis cases, Hp positivity continues despite the treatment, although the pathological severity changes. It is appropriate to discuss the effectiveness of routine treatments and to take culture/antibiogram, even bismuth including preparations to the forefront

🔖

Bu Makaleye Atıf Yap

HUT, A., ÇAKIR, M., KOYUNCU, A., DEĞERLİ, M. S., AKINCI, M., AKTÜRK, O. M., KOCAKUŞAK, A., YILDIRIM, D. (2022). The Efficacy of Combination Regime in Helicobacter Pylori Eradication: A Cross-Sectional Study from an Experienced Endoscopy Center. Haseki Tıp Bülteni, Cilt: 59 - Sayı: 5, 419–423. https://ajindex.com/articles/534998

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Alzahrani S, Lina TT, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Effect of Helicobacter pylori on gastric epithelial cells. World J Gastroenterol 2014;20:12767-80
  2. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 2007;21:205-14
  3. Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the ¹³C-Urea breath test. BMC Public Health 2013;13:1215
  4. Türk Cerrahi Derneği. Gastrointestinal Sistem Endoskopisi.; 2016. https://turkcer.org.tr/files/publications/86/ fbd58fceed748112cd1a7911d8df70df.pdf 5. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985;142:436-9. 6. de Brito BB, da Silva FAF, Soares AS, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019;25:5578-89
  5. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection [published correction appears in Am J Gastroenterol. Am J Gastroenterol 2017;112:212-39
  6. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81
  7. Yun J, Wu Z, Qi G, Han T, Zhang D. The high-dose amoxicillinproton pump inhibitor dual therapy in eradication of Helicobacter pylori infection. Expert Rev Gastroenterol Hepatol 2021;15:149-57
  8. FitzGerald R, Smith SM. An Overview of Helicobacter pylori Infection. Methods Mol Biol 2021;2283:1-14
  9. Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol 2018;24:3204-21
  10. Zagari RM, Frazzoni L, Marasco G, Fuccio L, Bazzoli F. Treatment of Helicobacter pylori infection: a clinical practice update. Minerva Med 2021;112:281-7
  11. Miyata E, Kudo T, Ikuse T, et al. therapy for Helicobacter pylori infection based on the antimicrobial susceptibility test in children: A single-center study over 12 years. Helicobacter 2021;26:e12764
  12. Cağdaş U, Otağ F, Tezcan S, Sezgin O, Aslan G, Emekdaş G. Mide Biyopsi Örneklerinden Helicobacter pylori'nin Tanımlanması ve Antimikrobiyal Direncinin Araştırılması [Detection of Helicobacter pylori and antimicrobial resistance in gastric biopsy specimens]. Mikrobiyol Bul 201